Archive for July 24th, 2008封存2008年7月24日

New Research Finds Relation Between Type 2 Diabetes And Gum Disease新的研究發現之間的關係2型糖尿病和牙周病

Thursday, July 24th, 2008 週四, 2008年7月24日

A new study published in the journal Diabetes Care, shows the relation between the type 2 diabetes and gum disease.一項新的研究發表在雜誌上的糖尿病照護,顯示之間的關係, 2型糖尿病和牙周病。 The study, though does not establish the gum disease as the direct reason behind type 2 diabetes, but it shows the relation between the two.研究,雖然沒有建立牙周病作為直接原因背後的2型糖尿病,但它表明之間的關係,二。 It can be added that this is the first study [...]可以說,這是首次研究[ … … ]

Living Cell Technologies Clinical Trial Proves Positive For All The Type 1 Diabetes Patients活細胞技術的臨床試驗證明,積極為所有1型糖尿病患者

Thursday, July 24th, 2008 週四, 2008年7月24日

Living Cell Technologies Limited has today released the results of their DiabeCell(R) trials on Six patients with insulin dependent (type 1) diabetes.活細胞技術有限公司今天公佈的結果,他們的diabecell ( )的審判六名病人與胰島素依賴型( 1型)糖尿病。 The company has released the results describing clinical benefit of the Company’s encapsulated porcine islet cells for the treatment of type 1 diabetes.該公司已公佈結果的臨床描述的利益,該公司的包裹豬胰島細胞移植治療1型糖尿病。

FA Device Could be Used to Detect Diabetes Before Its Diagnosis發裝置可用於檢測糖尿病之前,其診斷

Thursday, July 24th, 2008 週四, 2008年7月24日

According to the scientists of the University of Michigan, they have created a new instrument called as FA device which is capable of detecting the metabolic stress and tissue damage that occurs long before the first symptoms of the diabetes.根據科學家的密西根大學,他們創造了一種新的儀器稱為發裝置,能夠檢測代謝應激和組織損傷發生之前很久的第一症狀的糖尿病。

Glumetza (Type 2 Diabetic Drug) Would be Promoted In The US Market by Santarus glumetza ( 2型糖尿病的藥物)將促進在美國市場由santarus

Thursday, July 24th, 2008 週四, 2008年7月24日

According to the announcement done on 22 of July 2008, by Santarus Inc.(a renowned San Deigo based company), they have signed an agreement with Depomed Inc. to promote Glumetza (a diabetic drug ) in the US market.據宣布完成對22 08年7月,由santarus公司(一位著名的聖deigo基於公司) ,他們簽署了一項協議,與depomed公司,以促進glumetza (一糖尿病藥物)在美國市場上。